MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
GenKyoTex raises CHF 18 million in a Series C Venture Financing to develop NOX enzyme inhibitors.
Brennan CaruthersMay 24, 2011
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

FierceBiotech Names F-star a 2011 Fierce 15 Company.

Brennan CaruthersSeptember 6, 2011
Next

Covagen nominates Franz Hefti as new member of the Board of Directors.

Brennan CaruthersMay 16, 2011

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact